Literature DB >> 16596447

Inhibition of ClC-2 chloride channels by a peptide component or components of scorpion venom.

C H Thompson1, D M Fields, P R Olivetti, M D Fuller, Z R Zhang, J Kubanek, N A McCarty.   

Abstract

ClC chloride channels play essential roles in membrane excitability and maintenance of osmotic balance. Despite the recent crystallization of two bacterial ClC-like proteins, the gating mechanism for these channels remains unclear. In this study we tested scorpion venom for the presence of novel peptide inhibitors of ClC channels, which might be useful tools for dissecting the mechanisms underlying ClC channel gating. Recently, it has been shown that a peptide component of venom from the scorpion L. quinquestriatus hebraeus inhibits the CFTR chloride channel from the intracellular side. Using two-electrode voltage clamp we studied the effect of scorpion venom on ClC-0, -1, and -2, and found both dose- and voltage-dependent inhibition only of ClC-2. Comparison of voltage-dependence of inhibition by venom to that of known pore blockers revealed opposite voltage dependencies, suggesting different mechanisms of inhibition. Kinetic data show that venom induced slower activation kinetics compared to pre-venom records, suggesting that the active component(s) of venom may function as a gating modifier at ClC-2. Trypsinization abolished the inhibitory activity of venom, suggesting that the component(s) of scorpion venom that inhibits ClC-2 is a peptide.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16596447     DOI: 10.1007/s00232-005-0818-8

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  49 in total

1.  Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III.

Authors:  D B Simon; R S Bindra; T A Mansfield; C Nelson-Williams; E Mendonca; R Stone; S Schurman; A Nayir; H Alpay; A Bakkaloglu; J Rodriguez-Soriano; J M Morales; S A Sanjad; C M Taylor; D Pilz; A Brem; H Trachtman; W Griswold; G A Richard; E John; R P Lifton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

2.  Voltage-dependent inhibition of N- and P-type calcium channels by the peptide toxin omega-grammotoxin-SIA.

Authors:  S I McDonough; R A Lampe; R A Keith; B P Bean
Journal:  Mol Pharmacol       Date:  1997-12       Impact factor: 4.436

3.  Solution structure of Lqh-8/6, a toxin-like peptide from a scorpion venom--structural heterogeneity induced by proline cis/trans isomerization.

Authors:  E Adjadj; V Naudat; E Quiniou; D Wouters; P Sautière; C T Craescu
Journal:  Eur J Biochem       Date:  1997-05-15

4.  Fast and slow gating of CLC-1: differential effects of 2-(4-chlorophenoxy) propionic acid and dominant negative mutations.

Authors:  E C Aromataris; G Y Rychkov; B Bennetts; B P Hughes; A H Bretag; M L Roberts
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

5.  Identification of a region of strong discrimination in the pore of CFTR.

Authors:  N A McCarty; Z R Zhang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-10       Impact factor: 5.464

6.  Agitoxin footprinting the shaker potassium channel pore.

Authors:  A Gross; R MacKinnon
Journal:  Neuron       Date:  1996-02       Impact factor: 17.173

7.  Additional disruption of the ClC-2 Cl(-) channel does not exacerbate the cystic fibrosis phenotype of cystic fibrosis transmembrane conductance regulator mouse models.

Authors:  Anselm A Zdebik; John E Cuffe; Marko Bertog; Christoph Korbmacher; Thomas J Jentsch
Journal:  J Biol Chem       Date:  2004-03-07       Impact factor: 5.157

8.  Extracellular zinc ion inhibits ClC-0 chloride channels by facilitating slow gating.

Authors:  T Y Chen
Journal:  J Gen Physiol       Date:  1998-12       Impact factor: 4.086

9.  Inactivation of muscle chloride channel by transposon insertion in myotonic mice.

Authors:  K Steinmeyer; R Klocke; C Ortland; M Gronemeier; H Jockusch; S Gründer; T J Jentsch
Journal:  Nature       Date:  1991-11-28       Impact factor: 49.962

10.  A common molecular basis for three inherited kidney stone diseases.

Authors:  S E Lloyd; S H Pearce; S E Fisher; K Steinmeyer; B Schwappach; S J Scheinman; B Harding; A Bolino; M Devoto; P Goodyer; S P Rigden; O Wrong; T J Jentsch; I W Craig; R V Thakker
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

View more
  4 in total

1.  Isolation and characterization of a high affinity peptide inhibitor of ClC-2 chloride channels.

Authors:  Christopher H Thompson; Pedro R Olivetti; Matthew D Fuller; Cody S Freeman; Denis McMaster; Robert J French; Jan Pohl; Julia Kubanek; Nael A McCarty
Journal:  J Biol Chem       Date:  2009-07-01       Impact factor: 5.157

2.  Lubiprostone activates non-CFTR-dependent respiratory epithelial chloride secretion in cystic fibrosis mice.

Authors:  Kelvin D MacDonald; Karen R McKenzie; Mark J Henderson; Charles E Hawkins; Neeraj Vij; Pamela L Zeitlin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-09-19       Impact factor: 5.464

3.  A synthetic prostone activates apical chloride channels in A6 epithelial cells.

Authors:  Hui Fang Bao; Lian Liu; Julie Self; Billie Jeanne Duke; Ryuji Ueno; Douglas C Eaton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-29       Impact factor: 4.052

Review 4.  Research and progress on ClC‑2 (Review).

Authors:  Hongwei Wang; Minghui Xu; Qingjie Kong; Peng Sun; Fengyun Yan; Wenying Tian; Xin Wang
Journal:  Mol Med Rep       Date:  2017-05-18       Impact factor: 2.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.